Literature DB >> 28073175

Postreperfusion microcirculatory derangements after liver transplantation: Relationship to hemodynamics, serum mediators, and outcome.

Carlo Pulitano1,2,3, David Joseph2,3, Charbel Sandroussi2,3, Deborah Verran3, Phong Ho3, Ashe Debiasio3, Adriano Luongo1, Geoffrey W McCaughan1,2, Nicholas A Shackel1,2, Michael Crawford2,3.   

Abstract

Despite the growing data supporting the role of microcirculation in regulating liver function, little of this knowledge has been translated into clinical practice. The aim of this study is to quantify hepatic microcirculation in vivo using sidestream dark field (SDF) imaging and correlate these findings with hepatic blood flow, hemodynamic parameters, and soluble mediators. Postreperfusion hepatic microcirculation was assessed using SDF imaging. Hepatic microcirculation measurements included functional sinusoidal density (cm/cm2 ), sinusoidal diameter (μm), red blood cell velocity (μm/second), volumetric blood flow (pl/second), and flow heterogeneity (FH) index. The serum concentrations of endothelin 1 (ET-1) and other inflammatory markers were analyzed with Luminex technology. Portal venous and hepatic artery flows were measured using a flowmeter. Twenty-eight patients undergoing cadaveric liver transplantations have been included in this study. Early allograft dysfunction (EAD) occurred in 7 (25%) patients and was associated with microcirculatory dysfunction. Low arterial and portal flow, high dose of inotropes, cold ischemia time, steatosis, and high ET-1 levels were all associated with impaired microcirculation. The time interval between portal venous and hepatic arterial reperfusion significantly correlated with the changes of the liver grafts' microcirculation. EAD patients tended to have higher serum levels of ET-1 on postoperative days 1, 2, 5, and 7 (all P < 0.01). Serum levels of ET-1 correlated significantly with microcirculation parameters. In conclusion, postreperfusion hepatic microcirculation is a determinant of organ dysfunction after liver reperfusion and could be used to identify very early patients at risk of EAD. Liver Transplantation 23 527-536 2017 AASLD.
© 2017 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28073175     DOI: 10.1002/lt.24721

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  4 in total

Review 1.  Intraoperative Imaging Techniques to Visualize Hepatic (Micro)Perfusion: An Overview.

Authors:  Zühre Uz; Lucinda Shen; Dan M J Milstein; Krijn P van Lienden; Rutger-Jan Swijnenburg; Can Ince; Thomas M van Gulik
Journal:  Eur Surg Res       Date:  2020-07-13       Impact factor: 1.745

2.  The Macrophage Activation Marker Soluble CD163 is Associated With Early Allograft Dysfunction After Liver Transplantation.

Authors:  Karen L Thomsen; Francis P Robertson; Peter Holland-Fischer; Brian R Davidson; Rajeshwar P Mookerjee; Holger J Møller; Rajiv Jalan; Henning Grønbæk
Journal:  J Clin Exp Hepatol       Date:  2018-10-05

3.  Interpatient heterogeneity in hepatic microvascular blood flow during vascular inflow occlusion (Pringle manoeuvre).

Authors:  Lucinda Shen; Zühre Uz; Joanne Verheij; Denise P Veelo; Yasin Ince; Can Ince; Thomas M van Gulik
Journal:  Hepatobiliary Surg Nutr       Date:  2020-06       Impact factor: 7.293

4.  Analysis of Data from the Oxygen Persufflation in Liver Transplantation (OPAL) Study to Determine the Role of Factors Affecting the Hepatic Microcirculation and Early Allograft Dysfunction.

Authors:  Tamas Benkö; Jennifer Belker; Anja Gallinat; Jürgen W Treckmann; Andreas Paul; Thomas Minor; Dieter P Hoyer
Journal:  Ann Transplant       Date:  2019-08-16       Impact factor: 1.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.